Craft
Occurx

Occurx

Occurx Summary

Company summary

Overview
OccuRx is a company developing therapies for the treatment of ocular inflammation and fibrosis. It leverages its proprietary small molecule drugs to address the unmet clinical need for more targeted ocular therapies to enhance visual acuity and prevent vision loss in inflammatory and degenerative eye disease. The company offers OCX063, a small molecule drug with the potential to prevent the growth of new and abnormal blood vessels and reduce inflammation of the neurons in the retina.
Type
Private
Status
Active
Founded
2014
HQ
Melbourne, AU | view all locations
Website
https://occurx.com
Cybersecurity rating
Sectors

Key people

  • Chris Burns

    Chris Burns, VP, Drug Discovery and Pharmacology

    • Eric Daniels

      Eric Daniels, Chief Executive Officer

      • Ann Hamer

        Ann Hamer, Chief Operating Officer

        LocationsView all

        1 location detected

        • Melbourne, VIC HQ

          Australia

          Level 9/31 Queen St

        News

        Footer menu